Hologic hires former Baxter International chief as next CEO

April 8, 2026 - 09:01

Medical technology firm Hologic, Inc. has announced a significant leadership transition. José E. Almeida, the former Chairman and CEO of Baxter International, will assume the role of President and Chief Executive Officer, effective immediately. He succeeds Steve MacMillan, who is retiring after leading the company for nearly a decade.

Almeida brings extensive experience in the healthcare and life sciences sectors to his new position. During his tenure at Baxter, he navigated the global healthcare company through a period of strategic transformation. His background is expected to guide Hologic, a leader in women's health with a focus on breast and skeletal health, molecular diagnostics, and gynecologic surgery.

The outgoing CEO, Steve MacMillan, is credited with significantly strengthening Hologic's portfolio and market position. Under his leadership, the company saw substantial growth, particularly through its diagnostic technologies which played a critical role during the global pandemic. The board expressed gratitude for his service and leadership.

Almeida steps into the role as Hologic looks to build upon its core diagnostics and imaging businesses. In a statement, Almeida expressed his honor in joining the company and his commitment to advancing its mission of improving women's health worldwide through innovative medical technologies. The leadership change marks a new chapter for the Massachusetts-based company as it aims to sustain its industry momentum.